RT Journal Article
SR Electronic
T1 Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancer
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e007310
DO 10.1136/jitc-2023-007310
VO 11
IS 10
A1 Naqash, Abdul Rafeh
A1 McCallen, Justin D
A1 Mi, Emma
A1 Iivanainen, Sanna
A1 Marie, Mona A
A1 Gramenitskaya, Daria
A1 Clark, James
A1 Koivunen, Jussi Pekka
A1 Macherla, Shravanti
A1 Jonnalagadda, Sweta
A1 Polsani, Shanker
A1 Jiwani, Rahim Ali
A1 Hafiz, Maida
A1 Muzaffar, Mahvish
A1 Brunetti, Leonardo
A1 Stroud, Chipman R G
A1 Walker, Paul R
A1 Wang, Kun
A1 Chung, Youngmin
A1 Ruppin, Eytan
A1 Lee, Se-Hoon
A1 Yang, Li V
A1 Pinato, David J
A1 Lee, Joo Sang
A1 Cortellini, Alessio
YR 2023
UL http://jitc.bmj.com/content/11/10/e007310.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.